The ESA BIC Switzerland organization committee has onboarded a new cohort of six startups joining the 2026 edition. ESA BIC Switzerland supports Swiss startups that leverage space technologies for ...
The much-cited term ‘ecosystem’ means, not least, that all players in the start-up sector must grow together. That is why the simultaneous development of start-ups, investors and support organisations ...
On February 4th, Technopark Zurich will host the 2026 edition of the Italian Tech Forum. For the third consecutive year and the second under the ITF (Italian Tech Forum) brand, the Italian innovation ...
Technis renforce son leadership de la gestion énergétique des bâtiments et des installations thermiques avec l’acquisition de l’entreprise précurseur genevoise E-NNO. À l’heure où la performance énerg ...
Philanthropic initiative Venture Kick provides up to CHF 150,000 seed funding to Swiss startups and offers a well-structured entrepreneurial path toward building a winning business. Startups pitch to ...
Xer Tech has obtained an operational approval for flights Beyond Visual Line of Sight (BVLOS) with Xer Tech’s X8 drone in Switzerland and in Hungary. The approval opens a gateway to commercialize the ...
The freshly launched Relativity Collective is a highly selective pan-European student network for the next generation of founders. At the core of this initiative is the belief that Europe produces ...
The third cohort of the Microsoft for Startups Switzerland AI Tech Accelerator comprises 11 startups building AI-powered solutions across a wide range of industries. From February 2 to mid-April 2026, ...
Über 500 Vereine, Verbände und Genossenschaften im DACH-Raum nutzen bereits beUnity. Für die nächste Wachstumsphase holt das Zürcher Startup internationale Erfahrung an Bord: Alberto Toledo übernimmt ...
A record number of seventeen start-ups were selected for the fifth edition of the LeadiNNg to Scale-up programme, organised by Innovaud and IMD. Coming from a wide range of sectors, the start-ups met ...
Virometix has revealed encouraging Phase 1 data for their lead vaccine asset, V-212, a synthetic vaccine designed to prevent pneumococcal disease caused by Streptococcus pneumoniae. In parallel, ...
EPFL spinoff Aesyra has completed the clinical investigation evaluating the efficacy and safety of its flagship product, AesyBite™ Active. The intelligent oral device combines a customized oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results